Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Organovo

  • Organovo and ZenBio Form 3D Bioprinting Partnership
    Organovo Holdings and ZenBio are partnering to produce 3D human tissues for drug discovery ... ZenBio will provide validated cellular inputs for use by Organovo with its NovoGen(tm) ...
    2-20-2013
  • Bioprinting in 3D
    layers. 3D Models with 100% Human Tissue Organovo, a San Diego-based bioprinting company, ... Michael Renard, executive vice president of commercial operations at Organovo, told GEN ...
    2-13-2013
  • Tissue Engineering No Easy Cell
    And in 2010, Organovo introduced the first 3D bioprinter. Organovo does not yet sell its NovoGen MMX bioprinters but shares them with partners, corporate (Pfizer and United ...
    10-9-2012
  • People in the News
    ... Ruga appointed Jean-Michel Vernier, Ph.D. , as head of medicinal chemistry and added David Matthews, Ph.D. , to its scientific advisory board...Organovo appointed Eric Michael ...
    7-1-2012
  • People in the News
    She also worked at Transkaryotic Therapies before Shire acquired it in 2005. Organovo appointed Michael Renard to evp, commercial operations and promoted Sharon Collins Presnell, ...
    6-15-2012
  • Organovo Raises $6.5M to Advance 3-D Tissue Printing Platform
    Organovo raised $6.5 million in a private placement to fund continued development of its ... and therapeutic applications. Organovo Raises $6.5M to Advance 3-D Tissue ...
    2-15-2012

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll